AMUNDI ASSET MANAGEMENT US, INC. - ALLOGENE THERAPEUTICS INC ownership

ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 163 filers reported holding ALLOGENE THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.97 and the average weighting 0.5%.

Quarter-by-quarter ownership
AMUNDI ASSET MANAGEMENT US, INC. ownership history of ALLOGENE THERAPEUTICS INC
ValueSharesWeighting
Q1 2021$247,000
+39.5%
7,0000.0%0.00%
Q4 2020$177,000
-33.0%
7,0000.0%0.00%
Q3 2020$264,000
-12.0%
7,0000.0%0.00%
Q2 2020$300,000
+120.6%
7,0000.0%0.00%
Q1 2020$136,0007,0000.00%
Other shareholders
ALLOGENE THERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Vida Ventures Advisors, LLC 1,798,163$46,213,00013.24%
Wildcat Capital Management, LLC 1,716,370$44,111,0005.71%
TPG Group Holdings (SBS) Advisors, Inc. 18,716,306$481,009,0004.77%
Copernicus Capital Management, LLC 15,000$386,0004.67%
Coastal Bridge Advisors, LLC 301,240$7,742,0001.79%
Lombard Odier Asset Management (Switzerland) SA 914,416$23,500,0001.46%
Casdin Capital, LLC 2,100,000$53,970,0001.34%
Pier Capital, LLC 450,182$11,570,0001.20%
Ghost Tree Capital, LLC 150,000$3,855,0001.13%
Sessa Capital IM, L.P. 750,000$19,275,0000.95%
View complete list of ALLOGENE THERAPEUTICS INC shareholders